'Safe' photoantimicrobials for skin and soft-tissue infections

International Journal of Antimicrobial Agents

Volumn 36, Issue 1, 2010, Pages 14-18

  Wainwright, Mark ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Drug resistance; Erythrosine; Indocyanine green; Methylene blue; Non toxic dyes; Phloxine B; Photoantimicrobials

Indexed keywords

CRYSTAL VIOLET; ERYTHROSINE; INDOCYANINE GREEN; METHYLENE BLUE; PHLOXINE; PHOTOSENSITIZING AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; DRUG SAFETY; DRUG STRUCTURE; HUMAN; LIGHT DAMAGE; NONHUMAN; ONYCHOMYCOSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RED LIGHT; SHORT SURVEY; SKIN INFECTION; SOFT TISSUE INFECTION; THRUSH;

HUMANS; PHOTOSENSITIZING AGENTS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS;

EID: 77953027300     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.03.002     Document Type: Short Survey

References (41)

1. Browning C.H., Gulbransen R., Kennaway E.L., Thornton L.H.D. Flavine and brilliant green, powerful antiseptics with low toxicity to the tissues: their use in the treatment of infected wounds. Br Med J 1917, i:73-78.
2. Browning C.H., Gulbransen R., Thornton L.H.D. The antiseptic properties of acriflavine and proflavine, and brilliant green. Br Med J 1917, ii:70-75.
3. Assinder E.W. Acriflavine as a urinary antiseptic. Lancet 1936, i:304-305.
4. Creagh T.A., Gleeson M., Travis D., Grainger R., McDermott T.E.D., Butler M.R. Is there a role for in vivo methylene blue staining in the prediction of bladder tumour recurrence?. Br J Urol 1995, 75:477-479.
5. Meissner P.E., Mandi G., Witte S., Coulibaly B., Mansmann U., Rengelshausen J., et al. Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso. Malaria J 2005, 4:45.
6. Saji M., Taguchi S., Uchiyama K., Osono E., Hayama N., Ohkuni H. Efficacy of gentian-violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J Hosp Infect 1995, 31:225-228.
7. Raab O.Z. Uber die wirking fluoreszierender stoffe auf infusorien. Z Biol 1900, 39:524-546.
8. Wainwright M., Phoenix D.A., Laycock S.L., Wareing D.R.A., Wright P.A. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett 1998, 160:177-181.
9. Wainwright M., Phoenix D.A., Gaskell M., Marshall B. Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp. J Antimicrob Chemother 1999, 44:823-825.
10. Menezes S., Capella M.A.M., Caldas L.R. Photodynamic action of methylene blue: repair and mutation in Escherichia coli. J Photochem Photobiol B 1990, 5:505-517.
11. Ergaieg K., Seux R. A comparative study of the photoinactivation of bacteria by meso-substituted cationic porphyrin, rose Bengal and methylene blue. Desalination 2009, 246:353-362.
12. Singh H., Vadasz J.A. Singlet oxygen quenchers and the photodynamic inactivation of E. coli ribosomes by methylene blue. Biochem Biophys Res Comm 1977, 76:391-397.
13. Tuite E.M., Kelly J.M. New trends in photobiology: photochemical interactions of methylene blue and analogues with DNA and other biological substrates. J Photochem Photobiol B 1993, 21:103-124.
14. Wainwright M., Crossley K.B. Methylene blue-a therapeutic dye for all seasons?. J Chemother 2002, 14:431-443.
15. Unno N., Suzuki M., Yamamoto N., Inuzuka K., Sagara D., Nishiyama M., et al. Indocyanine green fluorescence angiography for intraoperative assessment of blood flow: a feasibility study. Eur J Vasc Endovasc Surg 2008, 35:205-207.
16. Wainwright M. Photosensitisers in biomedicine 2009, John Wiley & Sons Ltd., Chichester, UK, p. 237.
17. Brown S.B., Brown E.A., Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 2004, 5:497-508.
18. Kirsch A.J., Miller M.I., Hensle T.W., Chang D.T., Shabsigh R., Olsson C.A., et al. Laser tissue soldering in urinary tract reconstruction: first human experience. Urology 1995, 46:261-266.
19. Demidova T.N., Hamblin M.R. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother 2005, 49:2329-2335.
20. Günther W.H.H., Searle R., Sieber F. Structure-activity relationships in the antiviral and antileukemic photoproperties of merocyanine dyes. Semin Hematol 1992, 29:88-94.
21. Wood S., Metcalf D., Devine D., Robinson R. Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J Antimicrob Chemother 2006, 57:680-684.
22. Omar G.S., Wilson M., Nair S.P. Lethal photosensitization of wound-associated microbes using indocyanine green and near-infrared light. BMC Microbiol 2008, 8:111.
23. Matula T.I., Downie R.H. Genetic toxicity of erythrosine in yeast. Mutat Res 1984, 138:153-156.
24. Tardivo J.P., Del Giglio A., de Oliveira C.S., Gabrielli D.S., Junqueira H.C., Tada D.B., et al. Methylene blue in photodynamic therapy: from basic mechanisms to clinical applications. Photodiagnosis Photodyn Ther 2005, 2:175-191.
25. Teichert M.C., Jones J.W., Usacheva M.N., Biel M.A. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002, 93:155-160.
26. National Audit Office Reducing healthcare-associated infections in hospitals in England 2009, Stationery Office, London, UK.
27. Schultz E.W., Krueger A.P. Inactivation of Staphylococcus bacteriophage by methylene blue. Proc Soc Exp Biol Med 1928, 26:100-101.
28. T'ung T. In vitro photodynamic action of methylene blue on Trypanosoma brucei. Proc Soc Exp Biol Med 1938, 38:29-31.
29. Mohr H., Lambrecht B., Selz A. Photodynamic virus inactivation of blood components. Immunol Invest 1995, 24:73-85.
30. Wallis C., Melnick J.L. Photodynamic inactivation of poliovirus. Virology 1963, 21:332-341.
31. Felber T.D., Smith E.B., Knox J.M., Wallis C., Melnick J.L. Photodynamic inactivation of herpes simplex: report of a clinical trial. JAMA 1973, 223:289-292.
32. Mohr H., Lambrecht B., Knuever-Hopf J. Virus inactivated single-donor fresh plasma preparations. Infusionsther Transfusionsmed 1992, 19:79-83.
33. Szpakowska M., Reiss J., Graczyk A., Szmigielski S., Lasocki K., Grzybowski J. Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative. Int J Antimicrob Agents 1997, 8:23-27.
34. Demidova T.N., Hamblin M.R. Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol 2005, 71:6918-6925.
35. Dai T., Tegos G.P., Lu Z., Huang L., Zhiyentayev T., Franklin M.J., et al. Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother 2009, 53:3929-3934.
36. Lavergne S., Darmon M., Levy V., Azoulay E. Methemoglobinemia and acute hemolysis after tetracaine lozenge use. J Crit Care 2006, 21:112-114.
37. Thevarajah S., Huston T.L., Simmons R.M. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005, 189:236-239.
38. Wainwright M., Phoenix D.A., Marland J., Wareing D.R.A., Bolton F.J. A study of photobactericidal activity in the phenothiazinium series. FEMS Immunol Med Microbiol 1997, 19:75-80.
39. Wilson M., Dobson J., Harvey W. Sensitization of oral bacteria to killing by low-power laser radiation. Curr Microbiol 1992, 25:77-81.
40. Wilson M., Mia N. Sensitisation of Candida albicans to killing by low-power laser light. J Oral Pathol Med 1993, 22:354-357.
41. Rasooly A., Weisz A. In vitro antibacterial activities of phloxine B and other halogenated fluoresceins against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46:3650-3653.